FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Diana Hartel

Research Profile

Geographic Areas

New York City

Activities & Behaviors

Intravenous Substance Abuse

Disorders

Chemicals & Drugs

Concepts & Ideas

Phenomena

Procedures

Injections, Intravenous

Co-author Network

Publications

TOP 3
Kinga Cieloszyk; Diana M Hartel; Galina Moskaleva; Ellie E Schoenbaum
Effects of hepatitis C virus infection on menopause status and symptoms.
Tonya M Johnson; Hillel W Cohen; Andrea A Howard; Nanette Santoro; Michelle Floris-Moore; Julia H Arnsten; Diana M Hartel; Ellie E Schoenbaum
Attribution of menopause symptoms in human immunodeficiency virus-infected or at-risk drug-using women.
Diana M Hartel; Ellie E Schoenbaum; Yungtai Lo; Robert S Klein
Gender differences in illicit substance use among middle-aged drug users with or at risk for HIV infection.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Diana Hartel (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Kinga Cieloszyk; Diana M Hartel; Galina Moskaleva; Ellie E Schoenbaum
Effects of hepatitis C virus infection on menopause status and symptoms.
Menopause (New York, N.Y.) 2009;16(2):401-6.
2008: Tonya M Johnson; Hillel W Cohen; Andrea A Howard; Nanette Santoro; Michelle Floris-Moore; Julia H Arnsten; Diana M Hartel; Ellie E Schoenbaum
Attribution of menopause symptoms in human immunodeficiency virus-infected or at-risk drug-using women.
Menopause (New York, N.Y.) 2008;15(3):551-7.
2006: Diana M Hartel; Ellie E Schoenbaum; Yungtai Lo; Robert S Klein
Gender differences in illicit substance use among middle-aged drug users with or at risk for HIV infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(4):525-31.
2005: Ellie E Schoenbaum; Diana M Hartel; Yungtai Lo; Andrea A Howard; Michelle Floris-Moore; Julia H Arnsten; Nanette Santoro
HIV infection, drug use, and onset of natural menopause.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(10):1517-24.
2000: J McNeely; Ernest Drucker; Diana M Hartel; E Tuchman
Office-based methadone prescribing: acceptance by inner-city practitioners in New York.
Journal of urban health : bulletin of the New York Academy of Medicine 2000;77(1):96-102.
1999: Marc N Gourevitch; Diana M Hartel; Peter A Selwyn; Ellie E Schoenbaum; R S Klein
Effectiveness of isoniazid chemoprophylaxis for HIV-infected drug users at high risk for active tuberculosis.
AIDS (London, England) 1999;13(15):2069-74.
1999: Marc N Gourevitch; Diana M Hartel; Peter Tenore; Katherine Freeman; I Marion; J Hecht; J Lowinson
Three oral formulations of methadone. A clinical and pharmacodynamic comparison.
Journal of substance abuse treatment 1999;17(3):237-41.
1998: Diana M Hartel; Ellie E Schoenbaum
Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City.
Public health reports (Washington, D.C. : 1974) 1998;113 Suppl 1():107-15.
1996: Ellie E Schoenbaum; Diana M Hartel; Marc N Gourevitch
Needle exchange use among a cohort of injecting drug users.
AIDS (London, England) 1996;10(14):1729-34.
1996: Marc N Gourevitch; Diana M Hartel; Ellie E Schoenbaum; R S Klein
Lack of association of induration size with HIV infection among drug users reacting to tuberculin.
American journal of respiratory and critical care medicine 1996;154(4 Pt 1):1029-33.
1996: Marc N Gourevitch; Diana M Hartel; Ellie E Schoenbaum; Peter A Selwyn; K Davenny; G H Friedland; R S Klein
A prospective study of syphilis and HIV infection among injection drug users receiving methadone in the Bronx, NY.
American journal of public health 1996;86(8):1112-5.
1995: Diana M Hartel; Ellie E Schoenbaum; Peter A Selwyn; J Kline; K Davenny; R S Klein; G H Friedland
Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use.
American journal of public health 1995;85(1):83-8.
1994: P Alcabes; Peter A Selwyn; K Davenny; Diana M Hartel; Donna Buono; Ellie E Schoenbaum; R S Klein; G H Friedland
Laboratory markers and the risk of developing HIV-1 disease among injecting drug users.
AIDS (London, England) 1994;8(1):107-15.
1993: C H Silberstein; Mary O'Dowd; P Chartock; Ellie E Schoenbaum; Gerald Friedland; Diana M Hartel; F P McKegney
A prospective four-year follow-up of neuropsychological function in HIV seropositive and seronegative methadone-maintained patients.
General hospital psychiatry 1993;15(6):351-9.
1992: Peter A Selwyn; P Alcabes; Diana M Hartel; Donna Buono; Ellie E Schoenbaum; R S Klein; K Davenny; G H Friedland
Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection.
The New England journal of medicine 1992;327(24):1697-703.
1991: R F Khabbaz; Diana M Hartel; Michael D Lairmore; C R Horsburgh; Ellie E Schoenbaum; B Roberts; T M Hartley; Gerald Friedland
Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: an old infection?
The Journal of infectious diseases 1991;163(2):252-6.
1989: Peter A Selwyn; Diana M Hartel; W Wasserman; Ernest Drucker
Impact of the AIDS epidemic on morbidity and mortality among intravenous drug users in a New York City methadone maintenance program.
American journal of public health 1989;79(10):1358-62.
1989: Ellie E Schoenbaum; Diana M Hartel; Peter A Selwyn; R S Klein; K Davenny; M Rogers; C Feiner; Gerald Friedland
Risk factors for human immunodeficiency virus infection in intravenous drug users.
The New England journal of medicine 1989;321(13):874-9.
1989: Peter A Selwyn; Diana M Hartel; V A Lewis; Ellie E Schoenbaum; Sten Vermund; R S Klein; A T Walker; G H Friedland
A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.
The New England journal of medicine 1989;320(9):545-50.
1988: Peter A Selwyn; A R Feingold; Diana M Hartel; Ellie E Schoenbaum; Michael H Alderman; R S Klein; G H Friedland
Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS.
AIDS (London, England) 1988;2(4):267-72.